Initial experience with ACT™ periurethral adjustable balloons to treat urinary incontinence due to intrinsic sphincter deficiency in the pediatric population
- 29 August 2023
- journal article
- research article
- Published by Springer Nature in World Journal of Urology
- Vol. 41 (10) , 2767-2774
Abstract
Purpose To present our initial experience with periurethral adjustable continence therapy (ACT™) for urinary incontinence due to intrinsic sphincter deficiency (ISD) in children. Methods This is an approved prospective non-randomized pilot study (NCT03351634) aiming to treat children born with spinal dysraphism (SD) or exstrophy epispadias complex (EEC) with ACT™. Endpoints were patient-reported changes in daily pad count, 24-h Pad test and complications. Results Since April 2018, 13 children (six girls, seven boys) were implanted at the median age of 12 years (5–16). The etiology of incontinence was neurogenic ISD (7/13, 54%) and EEC (6/13, 46%). After ACT™ implantation, continence (no pad or 1 security pad/day) was achieved in 9(69%) patients (5/7 SD, 4/6 EEC). Additionally, two (15%) patients had a significant improvement (decreasing Pad test from 1049 to 310 g at 3 months). One patient (7%) had no improvement. Results were stable at 21 months (6–43) of follow-up. Mean final balloon volume was 2.89 ml (± 0.85) with a median of 3 fillings to obtain continence. We had four revisions due to cutaneous port erosion (n = 3) and balloon migration (n = 1) and two definitive explantations. PinQ score was significantly improved (47 vs 40.5 with balloon, p = ns). Neither degradation of the upper urinary tract nor cystomanometric changes have been observed at 6 and 12 months postoperatively. Conclusion Urinary incontinence due to ISD owing to EEC or SD can be successfully treated with ACT™ periurethral balloons. Given the minimal invasiveness of this therapy, it might be a first‐line option treatment in children with complex stress urinary incontinence.Keywords
This publication has 26 references indexed in Scilit:
- Treatment of Neurogenic Stress Urinary Incontinence Using an Adjustable Continence Device: 4-Year FollowupJournal of Urology, 2012
- Long-Term Effects of Endoscopic Injection of Dextranomer/Hyaluronic Acid Based Implants for Treatment of Urinary Incontinence in Children with Neurogenic BladderJournal of Urology, 2012
- International children's continence society's recommendations for therapeutic intervention in congenital neuropathic bladder and bowel dysfunction in childrenNeurourology and Urodynamics, 2012
- Long-Term Results of Bulking Agent Injection for Persistent Incontinence in Cases of Neurogenic Bladder DysfunctionJournal of Urology, 2010
- Artificial Urinary Sphincter in Children—Voiding or Emptying? An Evaluation of Functional Results in 44 PatientsJournal of Urology, 2008
- Etude française prospective multicentrique de l’utilisation des ballons ACT® pour le traitement de l’incontinence urinaire d’effort chez la femmeProgrès en Urologie, 2007
- 14 Years of Experience With the Artificial Urinary Sphincter in Children and Adolescents Without Spina BifidaJournal of Urology, 2006
- BLADDER NECK SLING FOR TREATMENT OF NEUROGENIC INCONTINENCE IN CHILDREN WITH AUGMENTATION CYSTOPLASTY: LONG-TERM FOLLOWUPJournal of Urology, 2005
- 10-YEAR EXPERIENCE WITH ARTIFICIAL URINARY SPHINCTER IN CHILDREN AND ADOLESCENTSJournal of Urology, 2001
- Artificial urinary sphincter implantation for neurogenic bladder: a multi‐institutional study in 107 childrenBritish Journal of Urology, 1996